Cargando…

Enhancing the clinical value of serum neurofilament light chain measurement

BACKGROUND: Serum neurofilament light chain (sNFL) is becoming an important biomarker of neuro-axonal injury. Though sNFL correlates with CSF NFL (cNFL), 40% to 60% of variance remains unexplained. We aimed to mathematically adjust sNFL to strengthen its clinical value. METHODS: We measured NFL in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosa, Peter, Masvekar, Ruturaj, Komori, Mika, Phillips, Jonathan, Ramesh, Vighnesh, Varosanec, Mihael, Sandford, Mary, Bielekova, Bibiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462467/ https://www.ncbi.nlm.nih.gov/pubmed/35737460 http://dx.doi.org/10.1172/jci.insight.161415

Ejemplares similares

Prognostic Value of Serum/Plasma Neurofilament Light Chain for COVID-19 Associated Mortality
por: Masvekar, Ruturaj R., et al.
Publicado: (2022)

Prognostic value of serum/plasma neurofilament light chain for COVID‐19‐associated mortality
por: Masvekar, Ruturaj R., et al.
Publicado: (2022)

Idebenone does not inhibit disability progression in primary progressive MS
por: Kosa, Peter, et al.
Publicado: (2020)

Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity
por: Masvekar, Ruturaj, et al.
Publicado: (2021)

Neurofilament Light Chain Levels Correlate with Clinical Measures in CLN3 Disease
por: Dang Do, An N., et al.
Publicado: (2020)

Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms
por: Kosa, Peter, et al.
Publicado: (2022)

Confounder-adjusted MRI-based predictors of multiple sclerosis disability
por: Kim, Yujin, et al.
Publicado: (2022)

Quantifications of CSF Apoptotic Bodies Do Not Provide Clinical Value in Multiple Sclerosis
por: Masvekar, Ruturaj, et al.
Publicado: (2019)

Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis
por: Pham, Linh, et al.
Publicado: (2021)

Machine learning-optimized Combinatorial MRI scale (COMRISv2) correlates highly with cognitive and physical disability scales in Multiple Sclerosis patients
por: Kelly, Erin, et al.
Publicado: (2022)

NeurEx: digitalized neurological examination offers a novel high‐resolution disability scale
por: Kosa, Peter, et al.
Publicado: (2018)

Serum neurofilament light chain measurements following nerve trauma
por: Wilcox, Matthew, et al.
Publicado: (2023)

Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis
por: Davies, Jennifer C, et al.
Publicado: (2023)

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
por: Sjölin, Karl, et al.
Publicado: (2022)

Comparing Neurofilament Light Chain Levels in Serum and Plasma
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis
por: Brenner, Juliette, et al.
Publicado: (2023)

Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia
por: Giannini, Lucia A.A., et al.
Publicado: (2023)

Serum neurofilament light chain is increased in hereditary spastic paraplegias
por: Wilke, Carlo, et al.
Publicado: (2018)

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
por: Hayashi, Tomohiro, et al.
Publicado: (2021)

Increased levels of neurofilament light chain in suicide attempters’ serum
por: Ramezani, Mahtab, et al.
Publicado: (2022)

Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis
por: Abdelhak, Ahmed, et al.
Publicado: (2023)

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
por: Meeter, Lieke H H, et al.
Publicado: (2019)

Prognostic value of neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
por: Godelaine, Joris, et al.
Publicado: (2021)

Serum neurofilament light chains in MS: Association with the Timed Up and Go
por: Allali, Gilles, et al.
Publicado: (2020)

Serum neurofilament light chain withstands delayed freezing and repeated thawing
por: Altmann, Patrick, et al.
Publicado: (2020)

Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation
por: Thebault, Simon, et al.
Publicado: (2021)

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021)

Factors influencing serum neurofilament light chain levels in normal aging
por: Koini, Marisa, et al.
Publicado: (2021)

Serum neurofilament light chain as a severity marker for spinocerebellar ataxia
por: Shin, Hye-Rim, et al.
Publicado: (2021)

Serum neurofilament light chain in COVID-19 and the influence of renal function
por: Körtvelyessy, Peter, et al.
Publicado: (2023)

Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022)

Identifying and Quantifying Neurological Disability via Smartphone
por: Boukhvalova, Alexandra K., et al.
Publicado: (2018)

The evaluation of serum brain‐derived neurotrophic factor and neurofilament light chain levels in patients with obstructive sleep apnea syndrome
por: Arslan, Burak, et al.
Publicado: (2021)

Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes
por: Natrajan, Muktha S., et al.
Publicado: (2015)

Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment
por: Walo-Delgado, Paulette Esperanza, et al.
Publicado: (2021)

Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value
por: Loeffler, Tina, et al.
Publicado: (2020)

Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden
por: Duering, Marco, et al.
Publicado: (2018)

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
por: Reinert, Marie-Christine, et al.
Publicado: (2020)

Serum neurofilament light chain as outcome marker for intensive care unit patients
por: Fisse, Anna Lena, et al.
Publicado: (2020)

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression
por: Mollenhauer, Brit, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_757miil6bdteulaf1ff75cgaln